Filing Flows › CorMedix (CRMD) › Recalls, complaints & regulation
CorMedix (CRMD): clinical trials
CorMedix (CRMD) beyond its filings: 2 active clinical trials.
CorMedix's latest quarter
CorMedix, Q2 2026: revenue $102M (+156% year over year), operating margin 42.1%, net earnings $26.0M, operating cash flow $86.2M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does CorMedix have?
2 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.